ID: ALA5189261

Max Phase: Preclinical

Molecular Formula: C26H37ClF3N5O9S2

Molecular Weight: 720.19

Associated Items:

Representations

Canonical SMILES:  CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CC[C@H](NS(=O)(=O)c1ccc(Cl)c(C(F)(F)F)c1)C(=O)O)C(N)=O

Standard InChI:  InChI=1S/C26H37ClF3N5O9S2/c1-13(2)10-19(23(39)33-17(22(31)38)8-9-45-3)34-24(40)20(12-36)32-21(37)7-6-18(25(41)42)35-46(43,44)14-4-5-16(27)15(11-14)26(28,29)30/h4-5,11,13,17-20,35-36H,6-10,12H2,1-3H3,(H2,31,38)(H,32,37)(H,33,39)(H,34,40)(H,41,42)/t17-,18-,19-,20-/m0/s1

Standard InChI Key:  ALBCHDABRGPJKY-MUGJNUQGSA-N

Associated Targets(Human)

Matrix metalloproteinase 7 1073 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 720.19Molecular Weight (Monoisotopic): 719.1673AlogP: 0.60#Rotatable Bonds: 19
Polar Surface Area: 234.09Molecular Species: ACIDHBA: 9HBD: 7
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.28CX Basic pKa: CX LogP: 0.42CX LogD: -3.01
Aromatic Rings: 1Heavy Atoms: 46QED Weighted: 0.11Np Likeness Score: -0.78

References

1. Tabuse H, Abe-Sato K, Kanazawa H, Yashiro M, Tamura Y, Kamitani M, Hitaka K, Gunji E, Mitani A, Kojima N, Oka Y..  (2022)  Discovery of Highly Potent and Selective Matrix Metalloproteinase-7 Inhibitors by Hybridizing the S1' Subsite Binder with Short Peptides.,  65  (19.0): [PMID:36137271] [10.1021/acs.jmedchem.2c01088]

Source